CLOs on the Move

Gentiva Health Services

www.gentiva.com

 
"Gentiva Health Services (NASDAQ: GTIV), formerly based in Melville, Long Island, New York and now in Atlanta, Georgia, is the largest provider of home health care, hospice and related services in the United States. Gentiva is a Fortune 1000 company with $1.7 billion in annual revenue. Gentiva is also a member of the S&P 600 index, developed by Standard & Poor's, featuring small capitalization U.S.-based stocks. The company offers a range of services, including nursing, physical, occupational, and speech-language therapy, cardiac and pulmonary care, disease and pain management, and other health and medical services. Gentiva provides health services to over ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.gentiva.com
  • 3350 Riverwood Pkwy SE Ste 1400
    Atlanta, GA USA 30339
  • Phone: 770.951.6450

Executives

Name Title Contact Details

Similar Companies

Hitachi Chemical Research Ctr.

Hitachi Chemical Research Ctr. is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Comprehensive Practice Management Services

Comprehensive Practice Management Services is a Lincoln, RI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Huron Medical Center

Huron Medical Center is committed to providing excellence in healthcare to our communities in a caring, compassionate manner. Huron Medical Center`s vision is to be the medical center for the communities served with continuous advancement of services offered.

axialHealthcare

axialHealthcare offers an evidence-driven, predictive solution that limits opioid misuse and optimizes care for patients with pain or opioid use disorder.

Nkarta Therapeutics

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.